Technology | Implantable Cardioverter Defibrillator (ICD) | September 14, 2015

Medtronic Receives FDA Approval for MR-conditional Implantable Cardioverter Defibrillator System

Device approved for use during full-body MRI scans for patients at risk of sudden cardiac arrest

Medtronic, Evera, ICD, MR-conditional, MRI, FDA approval

September 14, 2015 — Medtronic received the first U.S. Food and Drug Administration (FDA) approval for an implantable cardioverter defibrillator (ICD) system for use with magnetic resonance imaging (MRI) scans. The Medtronic Evera MRI SureScan ICD System is approved for MRI scans on any part of the body without positioning restrictions, which means that patients who depend on life-saving ICDs also now have access to MRI scans if and when they need them. The newly approved system, which will be commercially available in September 2015, includes the Evera MRI ICD and Sprint Quattro Secure MRI SureScan DF4 leads, which must be used together to be considered MR-conditional.

“Patients at risk for sudden cardiac arrest have long relied on ICDs to monitor their hearts, detect dangerous arrhythmias and deliver the life-saving therapy needed to survive,” said Michael R. Gold, M.D., Ph.D., chief of cardiology, Michael E Assey Professor of Medicine at the Medical University of South Carolina, and principal investigator in the Evera MRI Clinical Trial. “Many of these patients also need access to MRIs, so the approval of an ICD that can be used in an MRI environment is crucial, and can help provide patients with the peace of mind that they are receiving the best care available.”

Sudden cardiac arrest (SCA) is a sudden, abrupt loss of heart function that can result in death if not treated within minutes with an electrical cardioverter shock, which can be delivered by an ICD. MRI is considered the gold standard in soft-tissue imaging and is used regularly for the diagnosis of conditions such as stroke, cancer, Alzheimer’s disease, and muscle, bone and joint pain.

Until now, patients with ICD systems have been contraindicated by the FDA from receiving MRI scans because of potential interactions between the MRI and device function, which might result in risk to patients. These MRI restrictions have resulted in a critical unmet need as data have shown that, within four years, more than one-third of patients with ICDs – 36 percent – are likely to need an MRI.

The Evera MRI ICD system includes hardware and software design enhancements from previous generation devices that allow it to safely undergo full-body MRIs, while maintaining the same longevity, proven shock reduction and physiological size and shape of the original Evera ICD. The device is paired with the Sprint Quattro Secure MRI SureScan DF4 leads, with more than 10 years of proven performance with active monitoring, now tested for safe use in an MRI environment.

The FDA approval of the Evera MRI ICD system was based on safety and efficacy data from the Evera MRI Clinical Trial, a multicenter, prospective, randomized, controlled clinical trial that enrolled 275 patients at 42 centers around the world. Presented during a late-breaking clinical trial session at Heart Rhythm 2015, the Heart Rhythm Society’s 36th Annual Scientific Sessions, and published simultaneously in the Journal of the American College of Cardiology (JACC), these data demonstrated that the Evera MRI ICD system is safe and effective, and that full-body MRI scans did not affect its ability to deliver life-saving therapy.

For more information: www.medtronic.com

Related Content

More Patients Survive Sudden Cardiac Arrest With New EMS Technique

UTHealth’s Henry Wang, M.D., displays a newer type of emergency breathing tube that could save thousands of lives. Photo courtesy of Rob Cahill, UTHealth

News | Sudden Cardiac Arrest | August 28, 2018
A new study showed a change in the type of breathing tube paramedics use to resuscitate patients with sudden cardiac...
Videos | Sudden Cardiac Arrest | July 05, 2018
Malissa Wood, M.D., co-director of the Corrigan Women’s Heart Health Program, Massachusetts General Hospital, explain
Sudden cardiac arrest - Exposure to Air Pollution on Cold Days Can Trigger Sudden Cardiac Death in Women. #HRS2018
News | Sudden Cardiac Arrest | May 16, 2018
May 16, 2018 — A new study shows that women exposed to particular matter (PM) and lower temperatures for even a short
Videos | Sudden Cardiac Arrest | March 14, 2018
The Zoll LifeVest is a temporary, wearable defibrillator designed as a safety net for patients, especially those bein
Feature | Sudden Cardiac Arrest | January 31, 2018
January 31, 2018 — Overall survival has improved for the about 200,000 patients experiencing in-hospital cardiac arre
MRI May Predict Neurological Outcomes for Cardiac Arrest Survivors
News | Sudden Cardiac Arrest | October 18, 2017
Magnetic resonance imaging (MRI)-based measurements of the functional connections in the brain can help predict long-...
Health Insurance Expansion Linked to Fewer Sudden Cardiac Arrests
News | Sudden Cardiac Arrest | July 11, 2017
The incidence of sudden cardiac arrest, an often deadly loss of heart function, declined significantly among previously...
Cedars-Sinai Team Develops New Sudden Cardiac Arrest Risk Assessment Score
News | Sudden Cardiac Arrest | June 26, 2017
A Cedars-Sinai Heart Institute investigator and his team have developed a new risk assessment tool that brings...
wearable defibrillators prevent sudden cardiac death in pediatric patients
Feature | Sudden Cardiac Arrest | May 11, 2017
May 11, 2017 — A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in
Videos | Sudden Cardiac Arrest | October 28, 2016
This video, provided by Zoll, demonstrates how cardiologists can explain sudden cardiac death to patients.
Overlay Init